IDH WILDTYPE GLIOBLASTOMA
Clinical trials for IDH WILDTYPE GLIOBLASTOMA explained in plain language.
Never miss a new study
Get alerted when new IDH WILDTYPE GLIOBLASTOMA trials appear
Sign up with your email to follow new studies for IDH WILDTYPE GLIOBLASTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New Brain-Penetrating pill tested in fight against deadly recurrent brain cancer
Disease control Recruiting nowThis early-stage trial is testing a new oral drug called ERAS-801 in adults with a specific type of recurrent brain cancer (glioblastoma). The main goals are to check the drug's safety and see how it affects the tumor's energy use. Participants take the pill daily for a short tim…
Matched conditions: IDH WILDTYPE GLIOBLASTOMA
Phase: PHASE1 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
Could a simple clock change boost brain cancer treatment?
Disease control Recruiting nowThis study is testing whether the time of day a brain cancer patient takes their chemotherapy pill matters. Researchers want to see if taking the drug, temozolomide, in the morning or evening is easier for patients to stick to and if it affects their quality of life or outcomes. …
Matched conditions: IDH WILDTYPE GLIOBLASTOMA
Phase: NA • Sponsor: Ottawa Hospital Research Institute • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC